2 ms·
Dark public choice perspective: this is incentive compatible for pharmaceutical companies and governments who can now give out their guidelines and solutions wi
by bomewish 3y ago
Dark public choice perspective: this is incentive compatible for pharmaceutical companies and governments who can now give out their guidelines and solutions without as strong scrutiny.
Too cynical??
- Fomite 3y ago"incentive compatible" is doing a lot of heavy lifting in that sentence. Meta-analysis and systematic reviews were done before Cochrane, and will be done after it. And most pharma companies are banking on RCT results - Cochrane can't do systematic reviews before there's multiple studies, so it's significantly further downstream than what makes pharma money.
- bomewish 3y agoOK I buy that.